<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D0382A2-6DA7-4821-B607-0E8282751234"><gtr:id>4D0382A2-6DA7-4821-B607-0E8282751234</gtr:id><gtr:name>University of Colombo</gtr:name><gtr:address><gtr:line1>PO Box 1490</gtr:line1><gtr:line4>Colombo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Sri Lanka</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3C4A98AE-E216-488D-ABD5-B21CD9B10326"><gtr:id>3C4A98AE-E216-488D-ABD5-B21CD9B10326</gtr:id><gtr:name>Institute for Endemic Diseases IEND</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E1CC69FF-F01B-4F80-98A2-158B82EFC120"><gtr:id>E1CC69FF-F01B-4F80-98A2-158B82EFC120</gtr:id><gtr:name>Centre Muraz</gtr:name><gtr:address><gtr:line1>Centre Muraz</gtr:line1><gtr:line2>01 PO Box 153</gtr:line2><gtr:line3>Bobo-Dioulasso 01</gtr:line3><gtr:postCode>BP 390</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83131D05-1343-4FD7-B8F6-EE9130AD9AC1"><gtr:id>83131D05-1343-4FD7-B8F6-EE9130AD9AC1</gtr:id><gtr:name>Noguchi Memorial Inst for Medical Res</gtr:name><gtr:address><gtr:line1>College of Health Sciences</gtr:line1><gtr:line2>University of Ghana, Legon</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6B538A40-510A-4984-92B4-F4DDAEDFC87E"><gtr:id>6B538A40-510A-4984-92B4-F4DDAEDFC87E</gtr:id><gtr:name>University of Buea</gtr:name><gtr:address><gtr:line1>PO Box 63</gtr:line1><gtr:line2>South West Province</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Cameroon</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D0382A2-6DA7-4821-B607-0E8282751234"><gtr:id>4D0382A2-6DA7-4821-B607-0E8282751234</gtr:id><gtr:name>University of Colombo</gtr:name><gtr:address><gtr:line1>PO Box 1490</gtr:line1><gtr:line4>Colombo</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Sri Lanka</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3C4A98AE-E216-488D-ABD5-B21CD9B10326"><gtr:id>3C4A98AE-E216-488D-ABD5-B21CD9B10326</gtr:id><gtr:name>Institute for Endemic Diseases IEND</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60"><gtr:id>B06DBF11-FCBF-430E-AD9A-D0AE23BFFF60</gtr:id><gtr:name>Kwame Nkruma University of Science &amp; Tec</gtr:name><gtr:address><gtr:line1>KNUST</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1CC69FF-F01B-4F80-98A2-158B82EFC120"><gtr:id>E1CC69FF-F01B-4F80-98A2-158B82EFC120</gtr:id><gtr:name>Centre Muraz</gtr:name><gtr:address><gtr:line1>Centre Muraz</gtr:line1><gtr:line2>01 PO Box 153</gtr:line2><gtr:line3>Bobo-Dioulasso 01</gtr:line3><gtr:postCode>BP 390</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C"><gtr:id>B5EF3F61-D9B1-4752-91FA-0E7B5E6FF56C</gtr:id><gtr:name>Pasteur Institute Dakar</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B16D710A-5C40-44CA-A796-B37EC8935E99"><gtr:id>B16D710A-5C40-44CA-A796-B37EC8935E99</gtr:id><gtr:name>University of Michigan</gtr:name><gtr:address><gtr:line1>3003 S. State Street</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/845F7CA5-F786-40DF-B429-C727CA83C9CF"><gtr:id>845F7CA5-F786-40DF-B429-C727CA83C9CF</gtr:id><gtr:name>University of Bamako</gtr:name><gtr:address><gtr:line1>University of Bamako</gtr:line1><gtr:line3>Darsalam</gtr:line3><gtr:postCode>BP276</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/473F7B5C-70FE-4079-A7A4-9B33054D3495"><gtr:id>473F7B5C-70FE-4079-A7A4-9B33054D3495</gtr:id><gtr:name>University of Rome I (La Sapienza)</gtr:name><gtr:address><gtr:line1>University of Rome</gtr:line1><gtr:line2>Via Pietro Roselli</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83131D05-1343-4FD7-B8F6-EE9130AD9AC1"><gtr:id>83131D05-1343-4FD7-B8F6-EE9130AD9AC1</gtr:id><gtr:name>Noguchi Memorial Inst for Medical Res</gtr:name><gtr:address><gtr:line1>College of Health Sciences</gtr:line1><gtr:line2>University of Ghana, Legon</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6DCA7B7A-0111-4A7C-95CC-DEAD58B89132"><gtr:id>6DCA7B7A-0111-4A7C-95CC-DEAD58B89132</gtr:id><gtr:name>University of Stockholm</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6B538A40-510A-4984-92B4-F4DDAEDFC87E"><gtr:id>6B538A40-510A-4984-92B4-F4DDAEDFC87E</gtr:id><gtr:name>University of Buea</gtr:name><gtr:address><gtr:line1>PO Box 63</gtr:line1><gtr:line2>South West Province</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Cameroon</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CB0D71D3-7812-42A2-A84E-E97C6FE2D582"><gtr:id>CB0D71D3-7812-42A2-A84E-E97C6FE2D582</gtr:id><gtr:firstName>Dominic</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Kwiatkowski</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600230"><gtr:id>F6620C26-05B4-4D2F-B9DC-4337107A4B22</gtr:id><gtr:title>Genomic analysis of malaria resistance</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600230</gtr:grantReference><gtr:abstractText>Malaria is one of humankind?s most persistent and deadly foes, and is a significant determinant of global poverty - causing debilitating illness in approximately half a billion people each year. The greatest burden of the disease falls on African children - over a million die each year of malaria.

This project hinges on a key observation. Many people survive malaria infection and, after repeated exposure, develop some level of immunity.

Our challenge is to answer this question. What are the natural immune responses that protect people from dying or becoming ill due to malaria? Here are two examples of what we mean by an immune response: (1) the person makes antibodies that attach to molecule X on the surface of the parasite; (2) when white blood cells come into contact with a malaria parasite they release chemical Y that kills the parasite. Knowing the answer to this question would help enormously in designing an effective malaria vaccine.

Researchers have been tackling this question for almost a century - why is it so difficult to answer? Part of the problem is that people who are infected with malaria make a vast range of immune responses that have no protective benefit and some that may even be harmful. Searching through all these different immune responses to find those that protect people from becoming ill or dying is like searching for a needle in a haystack. To complicate matters further, much of the immune battle against the malaria parasite happens in the spleen and other inaccessible parts of the body that are very difficult to study in living people.

Recent advances in human genome research are revolutionising the way that we tackle complex problems of this sort. The key observation is that most human genes show variation between individuals. By investigating how this natural genetic variation affects the ability of people to resist infection, we can get deep insights into molecular mechanisms of protective immunity.

Why is this such a porful approach? Firstly, because it doesn?t require us to measure proteins directly, so we may be able to identify important mechanisms even if they are impossible to measure in living humans - e.g., if they are hidden away in the spleen. Secondly, because new technologies allow us to screen a vast number of genes without knowing anything about their function, making it possible to discover entirely novel mechanisms that are critical for protection against malaria.</gtr:abstractText><gtr:technicalSummary>A major obstacle to the development of a malaria vaccine, or improved treatments for severe malaria, is our poor understanding of the host responses that determine protective immunity. Genomic epidemiology offers a radically new approach to the problem, using natural human diversity as a tool to identify host genes that play a critical role in immunity and pathogenesis. 

The long-term goal of this MRC Programme, which began in 1996, is to achieve a comprehensive understanding of malaria resistance genes in human populations. It has 3 key objectives: 

1. establish epidemiological infrastructure to discover malaria resistance genes 

2. develop effective strategies for high-resolution genomic association mapping 

3. characterise functional genetic variants that affect immune gene regulation

All 3 areas have seen substantial progress over the past 5 years. We have established a unique epidemiological resource for large-scale genetic association analysis of malaria, which now contains more than 6000 cases of severe malaria plus parents and population controls. Building on the success of this MRC Programme, and on revolutionary advances in the science of human genomic diversity and genotyping technology, we have obtained funding from the Grand Challenges in Global Health initiative to establish a global network for genomic epidemiology of malaria (MalariaGEN) which will yield extremely large epidemiological collections across 14 malaria endemic countries, plus massive-throughput genotyping. Thus we expect to generate a vast amount of data over the next 5 years. However to achieve our long-term goal we need to do more than simply scale up sample size and genotyping capacity. Genomic epidemiology is a young science and there are many basic methodological issues to be addressed.

This proposal aims to tackle some of these fundamental problems. 

First, the huge genetic diversity of African populations poses a major challenge for genetic association analysis due to population stratification - we will address this problem both by detailed population sampling and by analytical approaches. 

Second, the complex haplotypic structure of the genome across different African populations greatly complicates the process of linkage disequilibrium mapping - this grant will fund an exceptionally high resolution survey of a single region of the genome, the MHC, across three populations. 

Third, we remain at a very early stage in understanding the functional basis of genetic variation in immune gene regulation - a problem we will tackle using allele-specific transcript quantification, an emerging technology to which our group has made a significant contribution over the past 3 years.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1478846</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>85DA2E41-1E6F-43F5-A93B-11BF2BE1114D</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-16</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bamako</gtr:collaboratingOrganisation><gtr:country>Mali, Republic of</gtr:country><gtr:department>Malaria Research and Training Centre (MRTC) Bamako</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>7DC6CA0B-5F3D-4045-B9DF-4884AE07C5E1</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-1</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Centre Muraz</gtr:collaboratingOrganisation><gtr:country>Burkina Faso</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>ECF437DE-5D2C-4BA8-BD02-D27BD0F842E3</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-12</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kwame Nkrumah University of Science and Technology (KNUST)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>52FC645E-1206-4D15-9413-BBE053D11F37</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-10</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Sanger Institute</gtr:description><gtr:id>75A4D0BB-715C-4B4D-917E-DE7E372449E0</gtr:id><gtr:impact>Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>dE6dfaLoRwL-1</gtr:outcomeId><gtr:partnerContribution>The Sanger Institute provides infrastructure, resources and expertise in large-scale genome sequencing, genome-wide SNP typing, informatics and functional genomics.</gtr:partnerContribution><gtr:piContribution>As head of the Malaria Programme and the Global Health Strategy Group at the Sanger Institute, I'm engaged in all levels of work - scientific, strategic and operational.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>Gambia, Republic of the</gtr:country><gtr:department>MRC Unit, The Gambia</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>EB24C398-0334-41E2-AD8D-0D285FE38EB1</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-5</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>C17DE939-3E03-46E1-B0D1-E335D04BCD60</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-2</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mahidol University</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>28D2AA54-4058-466C-98F6-417D09D12C56</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-7</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute for Endemic Diseases IEND</gtr:collaboratingOrganisation><gtr:country>Sudan, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>665E1E7A-7E28-464C-B539-7D4D611D2CB8</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-20</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>9005B72F-E1C1-4E6D-9AC1-6EB981525468</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-18</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>323750C2-AB59-4921-8571-E6C8AF05577E</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-15</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>015F78A3-9C96-41A5-8D1C-512E02DACEA6</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-3</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Multiple</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Buea</gtr:collaboratingOrganisation><gtr:country>Cameroon, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>9D3D72BA-16C0-4A6E-963B-A5E5FD31A121</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-9</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malawi</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>92D52416-4AF6-4FA9-8B1A-04F7A271DFCC</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-17</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>BD6F7338-8E5E-48C5-89A2-6062FED0C4A3</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-6</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Papua New Guinea Institute of Medical Research</gtr:collaboratingOrganisation><gtr:country>Papua New Guinea, Independent State of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>2620DFB2-B316-429B-BDCC-A812BFF7A8CA</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-19</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stockholm University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>5C98811B-3309-4ECA-B2DF-25941349F2E5</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-23</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Colombo</gtr:collaboratingOrganisation><gtr:country>Sri Lanka, Democratic Socialist Republic of</gtr:country><gtr:department>Department of Parasitology</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>35E38AF7-7B0E-430A-934D-557E5621B584</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-21</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sapienza University of Rome</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Parasitology Sapienza</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>41F2BA9A-5BEB-4A33-8995-73CF43310B05</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-14</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute Dakar</gtr:collaboratingOrganisation><gtr:country>Senegal, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>0B17B9A0-8890-4EDE-B4F9-DC80175D8AA3</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-8</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>B56E0C1D-989E-40D3-9229-29091B40C66F</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-4</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Michigan</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>CC6159D2-0320-4A31-8BA5-FD4950C206BF</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-13</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Centre for Vaccine Development (CVD)</gtr:department><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>AD3B0BCE-F17C-4654-98F7-0FE09F0443DF</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-22</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Noguchi Memorial Institute for Medical Research (NMRR)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:description>Malaria Genomic Epidemiology Network (MalariaGEN)</gtr:description><gtr:id>382FCC39-0754-4DCE-8BAE-6F68CC46E785</gtr:id><gtr:impact>See www.malariagen.net. Outputs are given in more detail in G0600718B. They include the development of the major global repository of samples and data for genomic epidemiology studies of malaria; and large-scale GWAS and genome sequencing data generation for host, parasite and vector.

Examples relevant to this grant:
1. The world's largest repository of DNA samples and clinical data for genetic studies of host-parasite interactions in malaria
2. Publication of the first genome-wide association study of human disease susceptibility in Africa
3. A large multicentre case-control study of severe malaria, representing the largest ongoing genome-wide association study of an infectious disease. In December 2011 we completed genotyping of &amp;gt;1 million SNPs on &amp;gt;20,000 individuals from 10 different populations.</gtr:impact><gtr:outcomeId>EJCE3jdbkTJ-11</gtr:outcomeId><gtr:partnerContribution>MalariaGEN - the Malaria Genomic Epidemiology Network - is a community of more than 100 researchers in 30 countries, working together on projects that require sharing and integration of large amounts of data.

MalariaGEN brings together the work of many different partner studies, each of which is led by an independent investigator and has its own scientific objectives. MalariaGEN adds value to partner studies by providing access to genotyping and sequencing technologies, and by providing a framework for sharing and integrating data in consortial and community projects. 

MalariaGEN provides training and support in genetic data analysis for researchers at partner institutions in malaria-endemic countries. We do this through a data bursary scheme and through an active programme of scientific meetings and training workshops. These activities are supported by the MalariaGEN Resource Centre which has a team of experts in statistics, population genetics and bioinformatics at the Sanger Institute, Oxford University, the London School of Hygiene and Tropical Medicine, and Mahidol University in Bangkok.

There are many practical and ethical challenges involved in sharing data across a global network comprising investigators and institutions with great disparities in funding and infrastructure. The MalariaGEN community has been working to develop transparent procedures for ethics and governance. We have a governance committee and an independent data access committee, and network policies have been defined for data sharing and data access.</gtr:partnerContribution><gtr:piContribution>I direct the MalariaGEN Resource Centre (http://www.malariagen.net/). CGGH supports Resource Centre activities, particularly statistics, software engineering, and ethics.</gtr:piContribution><gtr:sector>Learned Society</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Data submitted to European Genotyping Archive. Any bona fide researcher may apply for access via an Independent Data Access committee.</gtr:description><gtr:id>8F3295CB-707D-4A04-A377-EE1E6680EA67</gtr:id><gtr:impact>First genomewide association study performed in Africa. Papers in Nature Genetics and Nature Reviews Genetics. Development of an ethical policy for GWAS data release, in consultation with stakeholders in developing countries, published in Nature and PLoS Medicine.</gtr:impact><gtr:outcomeId>rqSRqDSodRS</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genomewide association studies of malaria in The Gambia, Ghana and Malawi</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2703FA7C-0364-4E87-B53E-6CF9C127FF52</gtr:id><gtr:title>BCG-malaria co-Infection has paradoxical effects on C57BL/6 and A/J mouse strains.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4415c5db701476546adae482ffa5e3c"><gtr:id>d4415c5db701476546adae482ffa5e3c</gtr:id><gtr:otherNames>Leisewitz AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn><gtr:outcomeId>oL5LYHj9T93</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC27C42-5273-42F1-8E68-4AFCE1257E2A</gtr:id><gtr:title>Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/360e88c87fe0a6aabe04c75f2b1f7322"><gtr:id>360e88c87fe0a6aabe04c75f2b1f7322</gtr:id><gtr:otherNames>Khor CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>WzUyTXTdHUG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E6CCDFD-7B58-4E1D-98BC-C07C1E3F81CE</gtr:id><gtr:title>Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9fd86636fb8c131dc84877c5ffeceff"><gtr:id>a9fd86636fb8c131dc84877c5ffeceff</gtr:id><gtr:otherNames>Fry AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>BLXgA5gMW6u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E5D1ED6-F7AC-46E1-9325-008F6FA2D6AA</gtr:id><gtr:title>Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311f5170e30802e247a129d0bc9c7053"><gtr:id>311f5170e30802e247a129d0bc9c7053</gtr:id><gtr:otherNames>Maiga B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>doi_55f9849840223a6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E3F32B5-5DEF-4E85-9256-EF7439BEA165</gtr:id><gtr:title>Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>S7topc3QUpP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A809EB3-EC46-4C80-8449-854F5B8B75E7</gtr:id><gtr:title>Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/352f94038690397c8c6983b598a6fb3f"><gtr:id>352f94038690397c8c6983b598a6fb3f</gtr:id><gtr:otherNames>Mangano VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>19646FD950E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B31143C-0A95-487A-BC5B-2FAFC6A586FC</gtr:id><gtr:title>Imputation-based meta-analysis of severe malaria in three African populations.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/184a9cdbbe27e8d87b2ff264d07e7075"><gtr:id>184a9cdbbe27e8d87b2ff264d07e7075</gtr:id><gtr:otherNames>Band G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_12926_en_1003509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDCF9A51-A60D-49EF-8DAE-1BC24B4569A3</gtr:id><gtr:title>Identification of common genetic variation that modulates alternative splicing.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03e6a3bfde72f8e69cf95014875c9ef1"><gtr:id>03e6a3bfde72f8e69cf95014875c9ef1</gtr:id><gtr:otherNames>Hull J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>m7jnVG1rsMA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7802256D-CF65-47E7-BB64-50DC500AEF47</gtr:id><gtr:title>Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1637c64bfb7cbdd99a0444713efdb96"><gtr:id>c1637c64bfb7cbdd99a0444713efdb96</gtr:id><gtr:otherNames>Auburn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>Xqo2k3CQzkb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59B6E6C-146B-44EB-B7B9-1497E9E59ED9</gtr:id><gtr:title>Co-introgression of Y-chromosome haplogroups and the sickle cell gene across Africa's Sahel.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82f077a0ace3bc58601f5732a11189ce"><gtr:id>82f077a0ace3bc58601f5732a11189ce</gtr:id><gtr:otherNames>Bereir RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>Q2xPQJgRr5n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F8256CA-E87A-40D5-A6E4-09CC924A059C</gtr:id><gtr:title>Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59c8927f7fa3f82838cb87de38be2f70"><gtr:id>59c8927f7fa3f82838cb87de38be2f70</gtr:id><gtr:otherNames>Dewasurendra RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_12926_26_22905743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C3AC3EC-8647-412A-85CA-64ED4C353E28</gtr:id><gtr:title>Association of the GNAS locus with severe malaria.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1637c64bfb7cbdd99a0444713efdb96"><gtr:id>c1637c64bfb7cbdd99a0444713efdb96</gtr:id><gtr:otherNames>Auburn S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>CA4FFA76E7E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DC35C31-83FB-4FC8-BB71-A05B61741B4A</gtr:id><gtr:title>Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c331ffefa59854e98bd12782e3f9eb9f"><gtr:id>c331ffefa59854e98bd12782e3f9eb9f</gtr:id><gtr:otherNames>Apinjoh TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e149e1492760d4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>834A18BD-6D25-4291-9E9D-1094DF79F93E</gtr:id><gtr:title>A genotype calling algorithm for the Illumina BeadArray platform.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>f37YjGG8Cub</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01C37EC4-4A80-4A9F-B6D3-1AD1015871CD</gtr:id><gtr:title>Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6cf9a3f2fbd3d841d9132978ec3e1c"><gtr:id>7b6cf9a3f2fbd3d841d9132978ec3e1c</gtr:id><gtr:otherNames>Clark TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>hEeGJPjLgvQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9981D736-D3B4-4431-B8E4-5B03B319631B</gtr:id><gtr:title>Candidate human genetic polymorphisms and severe malaria in a Tanzanian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04b51454b7779504ab271ad8bae5b911"><gtr:id>04b51454b7779504ab271ad8bae5b911</gtr:id><gtr:otherNames>Manjurano A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_23144702</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C120BD4-8806-4A56-BCD7-5524FE74E027</gtr:id><gtr:title>Ethical data release in genome-wide association studies in developing countries.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6c6b0bd68dab83386da1c22aa5e1376"><gtr:id>b6c6b0bd68dab83386da1c22aa5e1376</gtr:id><gtr:otherNames>Parker M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>1D1D7914E06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E755A2-7D05-4593-82EC-75086C4F2AD9</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>nLPv8QNP8dM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F39860A-CE7B-4E58-ACBB-51F17114B678</gtr:id><gtr:title>A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f31e9b5c9ba942f7103fc3038abbcc67"><gtr:id>f31e9b5c9ba942f7103fc3038abbcc67</gtr:id><gtr:otherNames>Diakite M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>B00832B1A5B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F6EC76-880D-440F-8322-B7A210BFA20E</gtr:id><gtr:title>Validating discovered Cis-acting regulatory genetic variants: application of an allele specific expression approach to HapMap populations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74857d2b9bd60c065bebd0bd630bb80d"><gtr:id>74857d2b9bd60c065bebd0bd630bb80d</gtr:id><gtr:otherNames>Campino S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>iy9ZSBpGrPy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B18CD7DD-7F58-44FB-848B-8E6B8DF51DB7</gtr:id><gtr:title>Haptoglobin genotype, anaemia and malaria in Gambian children.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3feaa99ac9202bc846815dd1eb8af32e"><gtr:id>3feaa99ac9202bc846815dd1eb8af32e</gtr:id><gtr:otherNames>Cox SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>ckymM8i3mpe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C390C674-0874-4A6B-B687-4CF666D5AE1F</gtr:id><gtr:title>Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c331ffefa59854e98bd12782e3f9eb9f"><gtr:id>c331ffefa59854e98bd12782e3f9eb9f</gtr:id><gtr:otherNames>Apinjoh TO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>pm_540e14ce14c51f755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F403B27-4604-4236-A9BB-E0A6009B50E5</gtr:id><gtr:title>Haptoglobin HP2-2 genotype, alpha-thalassaemia and acute seizures in children living in a malaria-endemic area.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1612233875e35533d4b4dd7030f63e"><gtr:id>1f1612233875e35533d4b4dd7030f63e</gtr:id><gtr:otherNames>Idro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>JrRD9H1LsoU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>580C278D-C503-4BC5-9A6B-713D5E3EA791</gtr:id><gtr:title>Candidate malaria susceptibility/protective SNPs in hospital and population-based studies: the effect of sub-structuring.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/058a2506ade8eabf570e35eff57e4cb9"><gtr:id>058a2506ade8eabf570e35eff57e4cb9</gtr:id><gtr:otherNames>Eid NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>YMaNebS1ue6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B9BD295-D71E-41B0-B626-EB0436D5C40B</gtr:id><gtr:title>Methodological challenges of genome-wide association analysis in Africa.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-0056</gtr:issn><gtr:outcomeId>tqjYGJYDFkt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DEC43E8-8151-47F4-B5EC-7C96AC655625</gtr:id><gtr:title>Classical sickle beta-globin haplotypes exhibit a high degree of long-range haplotype similarity in African and Afro-Caribbean populations.</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff557540ccc3c49c81a070d4a37566ad"><gtr:id>ff557540ccc3c49c81a070d4a37566ad</gtr:id><gtr:otherNames>Hanchard N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>QPhTR3eT9Yj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E0795A3-E0A7-4A4C-8A05-8A0A860EACDD</gtr:id><gtr:title>Loss of balancing selection in the betaS globin locus.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c95fda26e5a8ecc63419e9e25c2131eb"><gtr:id>c95fda26e5a8ecc63419e9e25c2131eb</gtr:id><gtr:otherNames>Salih NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>BZrGD9YMDZx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8C7EE76-096E-4C28-8587-626107F11E22</gtr:id><gtr:title>High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta.</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3fbe0e0bc4e694a8a98cf4b11f7e12"><gtr:id>8d3fbe0e0bc4e694a8a98cf4b11f7e12</gtr:id><gtr:otherNames>Daelemans C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn><gtr:outcomeId>pQ9GwsU1YpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>945F0772-C699-45B8-B902-489149A5B125</gtr:id><gtr:title>Reappraisal of known malaria resistance loci in a large multicenter study.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56cafcacf360f5.49177305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD8DB45-0161-4EC9-9646-A903F2D604DB</gtr:id><gtr:title>Context-specific functional effects of IFNGR1 promoter polymorphism.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a51fa642699a40f689c61f414e2e2e2"><gtr:id>7a51fa642699a40f689c61f414e2e2e2</gtr:id><gtr:otherNames>Koch O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>M5eUWvL4wdz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEFA9E8-CD83-42B9-B6D4-530094507854</gtr:id><gtr:title>Human candidate polymorphisms in sympatric ethnic groups differing in malaria susceptibility in Mali.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/311f5170e30802e247a129d0bc9c7053"><gtr:id>311f5170e30802e247a129d0bc9c7053</gtr:id><gtr:otherNames>Maiga B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f9849840550bb9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8052F34B-8747-4ACD-AC21-940249976415</gtr:id><gtr:title>African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04b51454b7779504ab271ad8bae5b911"><gtr:id>04b51454b7779504ab271ad8bae5b911</gtr:id><gtr:otherNames>Manjurano A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>doi_55f984984048f054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ABECA56-4692-41C1-922C-96262C5E9421</gtr:id><gtr:title>Resistance to malaria through structural variation of red blood cell invasion receptors.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318e66d904f7b6b4fc3e6ced1f5ec8f9"><gtr:id>318e66d904f7b6b4fc3e6ced1f5ec8f9</gtr:id><gtr:otherNames>Leffler EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5a2fda5b5e6771.72794638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E94DEB6-1A77-46FB-B85C-A7DF7E9F3EC9</gtr:id><gtr:title>Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_23029157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F5209BD-95A9-4C63-8427-EF11F49A8830</gtr:id><gtr:title>Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/352f94038690397c8c6983b598a6fb3f"><gtr:id>352f94038690397c8c6983b598a6fb3f</gtr:id><gtr:otherNames>Mangano VD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>XHM34uNc8Zy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CAE942D-B7C8-422A-BCBA-52C499A83FB5</gtr:id><gtr:title>Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/860dac34d351d7b825bf27a134678fb9"><gtr:id>860dac34d351d7b825bf27a134678fb9</gtr:id><gtr:otherNames>Callaghan MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>ce9X9Z3APAJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21765E4C-C8E8-48AA-9156-3A92224184D6</gtr:id><gtr:title>Investigating the potential for ethnic group harm in collaborative genomics research in Africa: is ethnic stigmatisation likely?</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf975219a341ef6a0ad35edc39efed7d"><gtr:id>cf975219a341ef6a0ad35edc39efed7d</gtr:id><gtr:otherNames>de Vries J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>doi_55f983983d0bc280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D51E754-0ACE-4BDE-8A7D-9D4DEDC44773</gtr:id><gtr:title>G6PD gene variants and its association with malaria in a Sri Lankan population.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59c8927f7fa3f82838cb87de38be2f70"><gtr:id>59c8927f7fa3f82838cb87de38be2f70</gtr:id><gtr:otherNames>Dewasurendra RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>doi_55f98498402b8d68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3A49CED-94E7-4337-AFD3-D49F73B1C75D</gtr:id><gtr:title>A novel locus of resistance to severe malaria in a region of ancient balancing selection.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5675ec0cef782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18F7DDF4-32B8-4EB0-9BEC-8E51F3010921</gtr:id><gtr:title>TLR9 polymorphisms in African populations: no association with severe malaria, but evidence of cis-variants acting on gene expression.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74857d2b9bd60c065bebd0bd630bb80d"><gtr:id>74857d2b9bd60c065bebd0bd630bb80d</gtr:id><gtr:otherNames>Campino S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn><gtr:outcomeId>nXCMRgu538N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>922C369C-D302-466C-B0B1-4FBB06B39564</gtr:id><gtr:title>Ethical issues in human genomics research in developing countries.</gtr:title><gtr:parentPublicationTitle>BMC medical ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf975219a341ef6a0ad35edc39efed7d"><gtr:id>cf975219a341ef6a0ad35edc39efed7d</gtr:id><gtr:otherNames>de Vries J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-6939</gtr:issn><gtr:outcomeId>pm_12926_26_21418562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>550DEFC0-3BD2-4518-B7A8-61D73F314F43</gtr:id><gtr:title>Whole genome-amplified DNA: insights and imputation.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>Xqi123yKCWe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD396BF1-844C-4E87-92EF-4137F1279B43</gtr:id><gtr:title>Candidate polymorphisms and severe malaria in a Malian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31822c14c5a3a09e9f8f63c9abe7e7d8"><gtr:id>31822c14c5a3a09e9f8f63c9abe7e7d8</gtr:id><gtr:otherNames>Toure O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22957039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36D4EC92-44B5-41C2-8DD4-17E8500E533B</gtr:id><gtr:title>A global network for investigating the genomic epidemiology of malaria.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feeb66dfd531cddbcbb3d20136782331"><gtr:id>feeb66dfd531cddbcbb3d20136782331</gtr:id><gtr:otherNames>Malaria Genomic Epidemiology Network</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>AKCZov6bGKd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B979E357-FDAA-40F7-88F2-66BE639EA391</gtr:id><gtr:title>Host genetic factors in resistance and susceptibility to malaria.</gtr:title><gtr:parentPublicationTitle>Parassitologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2364e383067c9dae1256d9e97f9ad0"><gtr:id>4e2364e383067c9dae1256d9e97f9ad0</gtr:id><gtr:otherNames>Kwiatkowski DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0048-2951</gtr:issn><gtr:outcomeId>BF74Rxn9BBW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A17BF21-BF63-47CC-9AD9-E69FD1E53EE1</gtr:id><gtr:title>Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9fd86636fb8c131dc84877c5ffeceff"><gtr:id>a9fd86636fb8c131dc84877c5ffeceff</gtr:id><gtr:otherNames>Fry AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>bRnPTCqhihd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D9CE6B9-EB67-4F53-86C0-658EC2CA09A7</gtr:id><gtr:title>Haplotype analyses of haemoglobin C and haemoglobin S and the dynamics of the evolutionary response to malaria in Kassena-Nankana District of Ghana.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fa50662721e3299542a7d46e01dc2df"><gtr:id>2fa50662721e3299542a7d46e01dc2df</gtr:id><gtr:otherNames>Ghansah A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22506028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6DF49B8-7843-422E-A6BD-B34ECD3146A0</gtr:id><gtr:title>Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4296ae1dc4f3be097c32fd50a800cdb6"><gtr:id>4296ae1dc4f3be097c32fd50a800cdb6</gtr:id><gtr:otherNames>Boraska V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>ZqE68dqFNvc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA46EF07-9E79-4BCD-B8B9-B86D20D2C6AE</gtr:id><gtr:title>The genetic risk of acute seizures in African children with falciparum malaria.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8e28e3419fde729cac6054c480b4645"><gtr:id>b8e28e3419fde729cac6054c480b4645</gtr:id><gtr:otherNames>Kariuki SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>pm_12926_26_23614351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C56BAD-6745-45EA-B207-8D786CD305E1</gtr:id><gtr:title>Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry.</gtr:title><gtr:parentPublicationTitle>Molecular autism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31305c7303f9432928d51385c3699364"><gtr:id>31305c7303f9432928d51385c3699364</gtr:id><gtr:otherNames>Sousa I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_55f983983d1d0582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2017E669-782F-43C9-AF04-4DFCC2020BDE</gtr:id><gtr:title>Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/594bd789adb90dc75633762079f81315"><gtr:id>594bd789adb90dc75633762079f81315</gtr:id><gtr:otherNames>Clarke GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58b427378b6873.40091008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40C0DA3F-11FA-4C48-B471-113213C1B6BF</gtr:id><gtr:title>Variation in human genes encoding adhesion and proinflammatory molecules are associated with severe malaria in the Vietnamese.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a4771316c7e1dbe5372ebf904680c01"><gtr:id>3a4771316c7e1dbe5372ebf904680c01</gtr:id><gtr:otherNames>Dunstan SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_12926_26_22673309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB8A89E0-ADBF-4BC1-BC0A-2349802AAA7D</gtr:id><gtr:title>Valid consent for genomic epidemiology in developing countries.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0443f4446943d1f2304774d28a33a7"><gtr:id>9e0443f4446943d1f2304774d28a33a7</gtr:id><gtr:otherNames>Chokshi DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>hC8soYL5dDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AFAC945-5A53-4895-94EC-406BAF3C5E4F</gtr:id><gtr:title>Power consequences of linkage disequilibrium variation between populations.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn><gtr:outcomeId>hkyjWJBeGfG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE0C04E-7C0D-40CB-846B-A977F329F627</gtr:id><gtr:title>Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4870a16829bec7267c64dd9870fb6734"><gtr:id>4870a16829bec7267c64dd9870fb6734</gtr:id><gtr:otherNames>Forton JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>86E32A145A9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDEB7DB2-0327-4C6E-AA83-FEC21074CF2E</gtr:id><gtr:title>Assessing genuine parents-offspring trios for genetic association studies.</gtr:title><gtr:parentPublicationTitle>Human heredity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81562ece86659bc9440adfcdc6069366"><gtr:id>81562ece86659bc9440adfcdc6069366</gtr:id><gtr:otherNames>Teo YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-5652</gtr:issn><gtr:outcomeId>LMc5RUWhxPf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5BA1270-FFB2-45AB-BC79-1DA8167292E8</gtr:id><gtr:title>Severe anemia in Malawian children.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd0a8d18cbfc579d8c4113ffce1eb32c"><gtr:id>dd0a8d18cbfc579d8c4113ffce1eb32c</gtr:id><gtr:otherNames>Calis JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>KP8HUByhNdt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>040A6A64-8823-4CA3-8B78-679548031588</gtr:id><gtr:title>Variation in the ICAM1 gene is not associated with severe malaria phenotypes.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9fd86636fb8c131dc84877c5ffeceff"><gtr:id>a9fd86636fb8c131dc84877c5ffeceff</gtr:id><gtr:otherNames>Fry AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_12926_16_18528404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B7CE46-C5B4-46F0-B242-A3248EA7A8EA</gtr:id><gtr:title>Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b6cf9a3f2fbd3d841d9132978ec3e1c"><gtr:id>7b6cf9a3f2fbd3d841d9132978ec3e1c</gtr:id><gtr:otherNames>Clark TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>ahmWDC6YnmS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D28570FE-EA60-44AE-869F-BFA0A7B41279</gtr:id><gtr:title>Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian Amazonian population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31dbb8b6b041b8d304c2602dd04d0700"><gtr:id>31dbb8b6b041b8d304c2602dd04d0700</gtr:id><gtr:otherNames>da Silva Santos S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12926_26_22615793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D006957-7CCF-47C6-A189-8253CA9AE5B6</gtr:id><gtr:title>A transcriptional switch underlies commitment to sexual development in malaria parasites.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c45025d5c4b3838d59823874e1446062"><gtr:id>c45025d5c4b3838d59823874e1446062</gtr:id><gtr:otherNames>Kafsack BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_540e149e149328f02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FC81881-2F9B-410D-BCCD-532F7EF350B0</gtr:id><gtr:title>Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>hKZqQ3WBfz2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600230</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>